Rallybio Corp SEC filings RLYB

Rallybio Corp has 308 filings in SEC EDGAR's recent list, going back to May 7, 2018. Its latest annual report, Form 10-K, was filed on Mar 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 27, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (officer or director change, shareholder vote results, other events). The company's fiscal year ends on December 31.

Rallybio Corp SEC filings
Form Description Filed Period
4 Insider transaction Nov 5, 2026 Nov 4, 2026
4 Insider transaction Nov 5, 2026 Nov 4, 2026
8-K Current report
Officer or director change, Shareholder vote results, Other events
Nov 4, 2026 Nov 4, 2026
4 Insider transaction Nov 3, 2026 Nov 2, 2026
4 Insider transaction Nov 2, 2026 Oct 29, 2026
4 Insider transaction Nov 2, 2026 Oct 29, 2026
4 Insider transaction Oct 30, 2026 Oct 28, 2026
4 Insider transaction Oct 29, 2026 Oct 27, 2026
4 Insider transaction Oct 28, 2026 Oct 26, 2026
4 Insider transaction Oct 28, 2026 Oct 26, 2026
10-Q Quarterly report Oct 27, 2026 Sep 30, 2026
425 Filing Oct 26, 2026 —
8-K Current report
Other events
Oct 26, 2026 Oct 25, 2026
4 Insider transaction Oct 20, 2026 Oct 16, 2026
4 Insider transaction Oct 20, 2026 Oct 16, 2026
EFFECT Filing Oct 15, 2026 —
424B3 Prospectus Oct 15, 2026 —
S-4/A S-4/a no. 4 Oct 14, 2026 —
4 Insider transaction Oct 14, 2026 Oct 12, 2026
4 Insider transaction Oct 13, 2026 Oct 9, 2026
4 Insider transaction Oct 8, 2026 Oct 6, 2026
S-4/A S-4/a no. 3 Oct 5, 2026 —
4 Insider transaction Oct 1, 2026 Sep 29, 2026
4 Insider transaction Sep 28, 2026 Sep 24, 2026
4 Insider transaction Sep 18, 2026 Sep 16, 2026
S-4/A S-4/a no. 2 Sep 16, 2026 —
8-K Current report
Officer or director change
Sep 9, 2026 Sep 8, 2026
S-4/A Filing Aug 26, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 6, 2026 —
10-Q Quarterly report Aug 6, 2026 Jun 30, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 4, 2026 —
S-4 Registration for a merger or exchange Jul 15, 2026 —
4 Insider transaction Jul 10, 2026 Jul 6, 2026
SCHEDULE 13G Ownership over 5% (passive) Jun 5, 2026 —
425 Filing Jun 1, 2026 —
8-K Current report
Material agreement, Unregistered share sale, Change in control, Officer or director change, Regulation FD disclosure
Jun 1, 2026 May 31, 2026
4 Insider transaction May 20, 2026 May 18, 2026
4 Insider transaction May 15, 2026 May 13, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G Ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G Ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G Ownership over 5% (passive) May 15, 2026 —
4 Insider transaction May 13, 2026 May 11, 2026
10-Q Quarterly report May 13, 2026 Mar 31, 2026
4 Insider transaction May 6, 2026 May 4, 2026
3 Initial insider ownership May 6, 2026 May 4, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) May 6, 2026 —
RW Filing May 5, 2026 —
8-K Current report
Agreement ended
May 4, 2026 May 3, 2026
SCHEDULE 13G Ownership over 5% (passive) Apr 29, 2026 —
S-4/A S-4/a no. 1 Apr 24, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 13, 2026 —
8-K Current report
Officer or director change
Mar 31, 2026 Mar 31, 2026
S-4 Registration for a merger or exchange Mar 17, 2026 —
10-K Annual report Mar 16, 2026 Dec 31, 2025
3 Initial insider ownership Mar 10, 2026 Mar 4, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 6, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Mar 6, 2026 —
SCHEDULE 13D/A Amended ownership over 5% (active) Mar 3, 2026 —
425 Filing Mar 2, 2026 —
8-K Current report
Material agreement, Unregistered share sale, Change in control, Officer or director change, Regulation FD disclosure
Mar 2, 2026 Mar 1, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Feb 27, 2026 —
4 Insider transaction Feb 23, 2026 Feb 18, 2026
4 Insider transaction Feb 20, 2026 Feb 18, 2026
4 Insider transaction Feb 20, 2026 Feb 18, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Jan 29, 2026 Jan 26, 2026
DEF 14A Proxy statement Jan 2, 2026 Jan 26, 2026
PRE 14A Preliminary proxy statement Dec 23, 2025 Jan 26, 2026
10-Q Quarterly report Nov 6, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 6, 2025 Nov 6, 2025
8-K Current report
Listing notice
Aug 29, 2025 Aug 26, 2025
10-Q Quarterly report Aug 7, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 7, 2025 Aug 7, 2025
8-K Current report
Material agreement, Acquisition or sale of assets, Other events
Jul 8, 2025 Jul 8, 2025
8-K Current report
Officer or director change
Jun 27, 2025 Jun 25, 2025
8-K Current report
Shareholder vote results
May 16, 2025 May 13, 2025
4 Insider transaction May 15, 2025 May 13, 2025
4 Insider transaction May 15, 2025 May 13, 2025
4 Insider transaction May 15, 2025 May 13, 2025
4 Insider transaction May 15, 2025 May 13, 2025
4 Insider transaction May 15, 2025 May 13, 2025
4 Insider transaction May 15, 2025 May 13, 2025
4 Insider transaction May 15, 2025 May 13, 2025
4 Insider transaction May 15, 2025 May 13, 2025
S-8 Employee stock plan registration May 9, 2025 —
10-Q Quarterly report May 8, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 8, 2025 May 8, 2025
8-K Current report
Other events
Apr 8, 2025 Apr 8, 2025
DEF 14A Proxy statement Apr 7, 2025 Dec 31, 2024
8-K Current report
Other events
Mar 13, 2025 Mar 13, 2025
424B5 Prospectus supplement Mar 13, 2025 —
10-K Annual report Mar 13, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 13, 2025 Mar 13, 2025
8-K Current report
Listing notice
Feb 25, 2025 Feb 24, 2025
4 Insider transaction Feb 19, 2025 Feb 14, 2025
4 Insider transaction Feb 19, 2025 Feb 14, 2025
4 Insider transaction Feb 19, 2025 Feb 14, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 12, 2025 —
4 Insider transaction Jan 6, 2025 Jan 2, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
SC 13G/A Amended ownership over 5% (passive) Nov 12, 2024 —
10-Q Quarterly report Nov 7, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 7, 2024 Nov 7, 2024
8-K Current report
Officer or director change
Sep 17, 2024 Sep 16, 2024
10-Q Quarterly report Aug 8, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 8, 2024 Aug 8, 2024
SC 13G Ownership over 5% (passive) Jul 30, 2024 —
SC 13G/A Amended ownership over 5% (passive) Jul 30, 2024 —
8-K Current report
Officer or director change
Jul 23, 2024 Jul 23, 2024
8-K Current report
Shareholder vote results
May 21, 2024 May 15, 2024
EFFECT Filing May 20, 2024 —
4 Insider transaction May 17, 2024 May 15, 2024
4 Insider transaction May 17, 2024 May 15, 2024
4 Insider transaction May 17, 2024 May 15, 2024
4 Insider transaction May 17, 2024 May 15, 2024
4 Insider transaction May 17, 2024 May 15, 2024
4 Insider transaction May 17, 2024 May 15, 2024
4 Insider transaction May 17, 2024 May 15, 2024
4 Insider transaction May 17, 2024 May 15, 2024
CORRESP Letter to the SEC May 16, 2024 —
UPLOAD Letter from the SEC May 16, 2024 —
S-3 Shelf registration May 10, 2024 —
10-Q Quarterly report May 9, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 9, 2024 May 9, 2024
D Filing Apr 22, 2024 —
DEF 14A Proxy statement Apr 11, 2024 Dec 31, 2023
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Apr 10, 2024 Apr 9, 2024
S-8 Employee stock plan registration Mar 13, 2024 —
10-K Annual report Mar 12, 2024 Dec 31, 2023
8-K Current report
Results of operations
Mar 12, 2024 Mar 12, 2024
4 Insider transaction Feb 16, 2024 Feb 15, 2024
4 Insider transaction Feb 16, 2024 Feb 15, 2024
4 Insider transaction Feb 16, 2024 Feb 15, 2024
4 Insider transaction Feb 16, 2024 Feb 15, 2024
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
SC 13D/A Amended ownership over 5% (active) Feb 12, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 9, 2024 —
8-K Current report
Results of operations, Exit or restructuring costs
Feb 6, 2024 Feb 6, 2024
4 Insider transaction Jan 4, 2024 Jan 2, 2024
4 Insider transaction Jan 4, 2024 Jan 2, 2024
SC 13G/A Amended ownership over 5% (passive) Jan 2, 2024 —
8-K Current report
Regulation FD disclosure
Dec 20, 2023 Dec 20, 2023
10-Q Quarterly report Nov 9, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 9, 2023 Nov 9, 2023
10-Q Quarterly report Aug 8, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 8, 2023 Aug 8, 2023
8-K Current report
Officer or director change
Jun 29, 2023 Jun 28, 2023
8-K Current report
Shareholder vote results
May 22, 2023 May 17, 2023
4 Insider transaction May 19, 2023 May 17, 2023
4 Insider transaction May 19, 2023 May 17, 2023
4 Insider transaction May 19, 2023 May 17, 2023
4 Insider transaction May 19, 2023 May 17, 2023
4 Insider transaction May 19, 2023 May 17, 2023
4 Insider transaction May 19, 2023 May 17, 2023
4 Insider transaction May 19, 2023 May 17, 2023
4 Insider transaction May 19, 2023 May 17, 2023
EFFECT Filing May 12, 2023 —
424B3 Prospectus May 12, 2023 —
CORRESP Letter to the SEC May 11, 2023 —
UPLOAD Letter from the SEC May 11, 2023 —
S-8 Employee stock plan registration May 10, 2023 —
S-3 Shelf registration May 9, 2023 —
10-Q Quarterly report May 9, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 9, 2023 May 9, 2023
DEF 14A Proxy statement Apr 10, 2023 May 17, 2023
4 Insider transaction Mar 16, 2023 Mar 14, 2023
4 Insider transaction Mar 9, 2023 Mar 7, 2023
4 Insider transaction Mar 9, 2023 Mar 7, 2023
10-K Annual report Mar 6, 2023 Dec 31, 2022
8-K Current report
Results of operations, Regulation FD disclosure
Mar 6, 2023 Mar 6, 2023
SC 13G/A Amended ownership over 5% (passive) Feb 9, 2023 —
4 Insider transaction Feb 6, 2023 Feb 6, 2023
4 Insider transaction Feb 6, 2023 Feb 6, 2023
4 Insider transaction Feb 6, 2023 Feb 6, 2023
SC 13G/A Amended ownership over 5% (passive) Feb 6, 2023 —
4 Insider transaction Feb 1, 2023 Feb 1, 2023
3 Initial insider ownership Feb 1, 2023 Feb 1, 2023
SC 13G/A Amended ownership over 5% (passive) Feb 1, 2023 —
8-K Current report
Officer or director change
Jan 31, 2023 Jan 31, 2023
SC 13G/A Amended ownership over 5% (passive) Jan 23, 2023 —
4 Insider transaction Jan 5, 2023 Jan 3, 2023
4 Insider transaction Jan 5, 2023 Jan 3, 2023
4 Insider transaction Jan 5, 2023 Jan 3, 2023
4 Insider transaction Jan 5, 2023 Jan 3, 2023
8-K Current report
Other events
Dec 1, 2022 Nov 28, 2022
4 Insider transaction Nov 17, 2022 Nov 15, 2022
SC 13G Ownership over 5% (passive) Nov 17, 2022 —
8-K Current report
Material agreement, Other events
Nov 14, 2022 Nov 10, 2022
424B5 Prospectus supplement Nov 14, 2022 —
424B5 Prospectus supplement Nov 10, 2022 —
10-Q Quarterly report Nov 7, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 7, 2022 Nov 7, 2022
8-K Current report
Regulation FD disclosure
Sep 28, 2022 Sep 28, 2022
EFFECT Filing Aug 15, 2022 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
RLYB (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
New Haven, CT
SEC filer status
, Emerging growth company
SEC CIK
1739410
Former names
Rallybio Holdings, LLC (until Jun 7, 2021)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.